Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Osteoarthritis Treatment Industry (Hand OA, Knee OA, Hip OA) Epidemiology Forecast to 2024 New Report Available at WiseGuyReports.com
By: PR Newswire Association LLC. - 27 Nov 2015Back to overview list

PUNE, India, Nov. 27, 2015 /PRNewswire-iReach/ -- Epidemiologists forecast an increase in the total prevalent cases of hand OA (Osteoarthritis) in the 7MM from 150,635,612 total prevalent cases in 2014 to 175,213,683 total prevalent cases in 2024 at an AGR of 1.63% during the forecast period. GlobalData epidemiologists forecast that the total prevalent cases of knee OA (Osteoarthritis) in the 7MM are expected to increase from 110,840,501 total prevalent cases in 2014 to 127,929,359 total prevalent cases in 2024 at an AGR of 1.54% during the forecast period. Complete Report Details Available @ https://wiseguyreports.com/reports/epicast-report-osteoarthritis-epidemiology-forecast-to-2024 .

Photo - http://photos.prnewswire.com/prnh/20151127/291350LOGO

Epidemiologists forecast that the total prevalent cases of hip OA (Osteoarthritis) in the 7MM are expected to increase from 61,150,916 total prevalent cases in 2014 to 69,699,696 total prevalent cases in 2024 at an AGR of 1.4% during the forecast period. The diagnosed prevalent cases of hand OA (Osteoarthritis) in the 7MM are expected to increase from 61,045,590 diagnosed prevalent cases in 2014 to 70,996,375 diagnosed prevalent cases in 2024 at an AGR of 1.63% during the forecast period. The diagnosed prevalent cases of knee OA (Osteoarthritis) in the 7MM are expected to increase from 37,845,305 diagnosed prevalent cases in 2014 to 43,877,213 diagnosed prevalent cases in 2024 at an AGR of 1.59% during the forecast period. The diagnosed prevalent cases of hip OA (Osteoarthritis) in the 7MM are expected to increase from 15,116,094 diagnosed prevalent cases in 2014 to 17,276,030 diagnosed prevalent cases in 2024 at an AGR of 1.43% during the forecast period.

OA is a degenerative disease of the entire joint, which involves the cartilage, joint lining, ligaments, and underlying bone. OA is the most common form of joint disease. The most affected joints are the knee, hip, hand, and spine. The disease's onset is gradual and typically seen in middle-aged to elderly people. OA is characterized by pain, stiffness, swelling, crepitus, and limited movement of the affected joint. OA will be the fourth leading cause of disability by the year 2020.

Make an enquiry before buying this Report at https://wiseguyreports.com/enquiry/epicast-report-osteoarthritis-epidemiology-forecast-to-2024 .

Scope

- The Osteoarthritis (OA) EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for hand OA, knee OA, and hip OA in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). The report also includes a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of hand OA, knee OA, and hip OA segmented by age and sex in these markets.

- The OA epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The OA EpiCast series will allow you to -

- Develop business strategies by understanding the trends shaping and driving the global OA market.

- Quantify patient populations in the global OA market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for OA therapeutics in each of the markets covered.

Inquire for Discount at https://wiseguyreports.com/check_discount/epicast-report-osteoarthritis-epidemiology-forecast-to-2024 .

Table of Content

1 Table of Contents 6 
1.1 List of Tables 7 
1.2 List of Figures 9 
2 Introduction 10 
2.1 Catalyst 10 
2.2 Related Reports 12 
3 Epidemiology 13 
3.1 Disease Background 13 
3.2 Risk Factors and Comorbidities 14 
3.3 Global Trends 16 
3.3.1 Total Prevalence of OA - 7MM 16 
3.3.2 Diagnosed Prevalence of OA - 7MM 16 
3.4 Forecast Methodology 20 
3.4.1 Sources Used 27 
3.4.2 Sources Not Used 32 
3.4.3 Forecast Assumptions and Methods 33 
3.5 Epidemiological Forecast for OA (2014-2024) 38 
3.5.1 Total Prevalent Cases 38 
3.5.2 Total Prevalent Cases of Hip OA by Sex 51 
3.5.3 Diagnosed Prevalent Cases 53 
3.5.4 Severity of Knee OA based on KL Grades 69 
3.6 Discussion 70 
3.6.1 Epidemiological Forecast Insight 70 
3.6.2 Limitations of the Analysis 71 
3.6.3 Strengths of the Analysis 72 
4 Appendix 73 
4.1 Bibliography 73 
4.2 About the Authors 77 
4.2.1 Epidemiologists 77 
4.2.2 Reviewers 77 
4.2.3 Global Director of Therapy Analysis and Epidemiology 78 
4.2.4 Global Head of Healthcare 79 
4.3 About GlobalData 80 
4.4 About EpiCast 80 
4.5 Disclaimer 81

Contact for More Information at sales@wiseguyreports.com  or +1 (646) 845 9349 (US) and +44 208 133 9349 (UK)

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Media Contact: Norah Trent, WiseGuy Reports, +1 646 845 9349, sales@wiseguyreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE WiseGuy Reports

Copyright 2015 PR Newswire Association LLC. Back to overview list
to the top ↑